These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 21654499)

  • 1. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
    Worodria W; Massinga-Loembe M; Mazakpwe D; Luzinda K; Menten J; Van Leth F; Mayanja-Kizza H; Kestens L; Mugerwa RD; Reiss P; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):32-7. PubMed ID: 21654499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.
    Worodria W; Massinga-Loembe M; Mayanja-Kizza H; Namaganda J; Kambugu A; Manabe YC; Kestens L; Colebunders R
    Clin Dev Immunol; 2011; 2011():758350. PubMed ID: 21197091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis.
    Conesa-Botella A; Goovaerts O; Massinga-Loembé M; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Colebunders R; Kestens L;
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1517-21. PubMed ID: 23044447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.
    Pac L; Horwitz MM; Namutebi AM; Auerbach BJ; Semeere A; Namulema T; Schwarz M; Bbosa R; Muruta A; Meya DB; Manabe YC
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e69-76. PubMed ID: 25761234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study.
    Deribe K; Yami A; Deribew A; Mesfin N; Colebunders R; Van Geertruyden JP; Woldie M; Maja T
    J Int Assoc Provid AIDS Care; 2015; 14(3):269-73. PubMed ID: 23966102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.
    Manosuthi W; Chottanapand S; Thongyen S; Chaovavanich A; Sungkanuparph S
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):42-6. PubMed ID: 16885778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
    Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
    HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
    Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
    Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
    Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
    Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
    PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
    Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
    AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
    Breton G; Bourgarit A; Pavy S; Bonnet D; Martinez V; Duval X; Longuet P; Abgrall S; Simon A; Leport C;
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1365-70. PubMed ID: 23107635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and pattern of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in patients on anti-retroviral therapy: An observational study.
    Nayak B; Panda RK; Mohanty T; Sahu L
    Indian J Tuberc; 2024 Jul; 71(3):291-296. PubMed ID: 39111937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.
    Castelnuovo B; Manabe YC; Kiragga A; Kamya M; Easterbrook P; Kambugu A
    Clin Infect Dis; 2009 Sep; 49(6):965-72. PubMed ID: 19673615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.